Regeneus Ltd receives approval for Progenza osteoarthritis trial
Regeneus, a clinical stage regenerative medicine company focused on the development of cell therapies, announced today that it has received ethics approval for a clinical trial of its new…
Source: www.medicalnewstoday.com